FDA authorizes Quidel's at-home COVID-19 antigen test

The FDA granted emergency use authorization March 1 to Quidel's at-home COVID-19 antigen test. 

The Quidel QuickVue At-Home COVID-19 Test is authorized for prescription use and doesn't require test samples to be sent to a lab. 

Patients ages 14 and older can self-administer the test using a nose swab. The test can be used on people as young as 8 if the sample is collected by an adult, the FDA said. 

The test is intended for people suspected of having COVID-19 by their healthcare provider within the first six days of their symptom onset. 

Read the full news release here

More articles on supply chain:
COVID-19 vaccine shortfall prompts UW Health to reschedule thousands of appointments
Medical devicemaker recalls patient lift after 2 deaths reported
Walgreens to sell LabCorp COVID-19 PCR test over the counter


© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.